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ABSTRACT
Background and Aims. Orthotopic liver transplantation (OLT) has been the standard
treatment for end-stage acute and chronic liver disease. Ischemia-reperfusion (I/R) injury
is one of the major causes of poor graft function early after OLT, and adversely influencing
graft and patient survivals. It is unknown whether I/R injury influences liver fibrogenesis.
Materials and Methods. Livers from 25 adult maleWistar rats were randomly assigned into 5
experimental groups according to the preservation solution: saline solution (SS); University of
Wisconsin (UW) solution; Fructose 1, 6-biphosphate (FBP); S-Nitroso-N-Acetylcysteine (SNAC):
or UW  SNAC (SNACUW). Aspartate aminotransferase (AST), alanine aminotransferase
(ALT), and lactic dehydrogenase (LDH) were determined in preservation solution samples at 2, 4,
and 6 hours. After 6 hours of cold ischemia, ex situ reperfusion was applied to the liver for 15
minutes. Serum AST, ALT, LDH, and renin levels were determined. Fresh liver slices were
processed for histological studies, determination of thiobarbituric acid reactive substances, catalase,
and glutathione, and expression of TGF-1 and angiotensin II AT1 receptor.
Results. AST was significantly lower during cold storage with UW than with the older media
(P .001);ALTwas lower in theFBPgroup (P .023) andLDHwas lower in theFBPandSNAC
groups (P .007). After reperfusion, serumAST, ALT, LDH, and TBARS showed no significant
differences among the groups. Catalase was significantly lower in the SS and FBP groups (P .008
and P  .006, respectively). Compared with UW, glutathione concentrations were significantly
higher in SS, FBP, and SNAC 200 (P  .004). Renin levels were significantly lower in the FBP
group (P .022). No histological signs of preservation injury were observed in the hepatic sample.
No expressions were detected of TGF-1 or AT1 receptor.
Conclusion. In this experimental model of early reperfusion injury, preservation changes
related to higher levels of renin, which suggest its role in fibrogenesis. FBP was associated
with lower renin levels than other solutions including UW.
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Oliveira, 1444 apto. 401, 90630-000, Porto Alegre, Brazil.ORTHOTOPIC liver transplantation (OLT) has beenthe standard treatment for patients suffering from
cute and chronic liver disease,1–4 but preservation injury
ontinues to be the major cause of poor graft function or
raft loss after the procedure.5–8 Moreover, it has been
suggested that preservation injury relates to hepatitis C
virus recurrence.9
University of Wisconsin (UW) solution is widely used for
organ preservation, but it is expensive and also displays a
high viscosity. As ischemia-reperfusion (I/R) injury contin-
ues to occur with UW, other solutions have been studied. E-mail: vrcamacho@terra.com.br
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I/R AND FIBROGENESIS 3635We are currently examining alternatives such as Fructose
1–6 Bisphosphate (FBP) and S-Nitroso-N-Acetylcysteine
(SNAC) in experimental models.
I/R injury relates to oxidative stress and release of
pro-inflammatory cytokines. We hypothesized that these
events can lead to fibrogenesis early after the transplanta-
tion. In fact, the fibrogenesis process is regulated by a
cascade of cytokines, like angiotensin II and 1 growth
factor (TGF-1).10,11 This study was designed to determine
hether I/R induced fibrogenesis and if other solutions
rotected against or aggrevated it compared with UW.
MATERIAL AND METHODS
Animals
An experimental study was performed using adult male Wistar rats
weighing 300–450 g provided by the Laboratory Animal Repro-
duction and Experimentation Center (CREAL) at Health Sciences
Institute at Federal University of Rio Grande do SuI (UFRGS)
and kept at our Animal Experimentation Unit (UEA). This study
was performed in accordance with the Guide for Care and Use of
Laboratory Animals and approved by our Ethics Committee.
Preservation Solutions
Five solutions were studied: (1) saline solution 0.9% (SS); (2) UW
(Viaspan, Bristol-Myers-Squibb, 1000 mL); (3) FBP; (4) synthe-
sized SNAC (Sigma Chemical, St Louis, Mo, United States in an
acidic solution of sodium nitrite12; and (5) UW SNAC 200 nmol.
Experimental Design
To have their livers removed, animals were anesthetized with
inhalation isofluorane 1.5%. The organs were kept in preservation
solutions for 6 hours. The subsequent procedures have been
previously published by our group.13
Biochemical Variables
Aspartate aminotransferase (AST), alanine aminotransferase
(ALT), and lactic dehydrogenase (LDH) were measured in cold
preservation solution at 2, 4, and 6 hours as well as intra-cardiac
blood. Roche/Hitachi Analyzer and Roche Diagnostics Reagents
were used to execute standard methods. Renin (kit Renin Maia,
Adautis) was determined in the intra-cardiac blood.
Hepatic Measurement of TBARS, Catalase,
and Glutathione
To determine TBARS, the hepatic fragment was warmed with
thiobarbituric acid (0.67%) and trichloroacetic acid (10%) for 15
minutes. The ruddy product after refrigeration and centrifugation
was quantified using spectrophotometry in 535 nm. Catalase activ-
ity was assayed according to the method of Aebi (1983) by
measuring the absorbance decrease at 240 nm in 10 l of supernate
using a medium of 20 mmol/L H2O2, 0.1% Triton X-100, and 10
mol/L potassium phosphate buffer, pH 7.0. Enzyme activity was
xpressed as micromoles of H2O2 consumed per minute per
illigram protein.14 Reduced glutathione in the hepatic tissue was
valuated using the DTNB method.15
Histological Analysis
A mean of 7 g liver tissue were fixed in 10% formalin, embedded in
paraffin, sectioned, and stained with hematoxylin-eosin. The ana-lyzed parameters included steatosis, hepatocyte vacuolization, neu-
trophilia, and sinusoidal congestion. All samples were evaluated by
2 blinded pathologists.
Immunohistochemistry
The expressions of TGF 1 and AT1 receptor of angiotensin II
(AT1) in liver tissue after reperfusion were determined using
immunohistochemistry by 2 observers independently. Where their
findings diverged, agreement was reached after discussion. A
semiquantitative scale was used to standardize the immunohisto-
chemical evaluation for the subsequent statistical analysis. The
expression ratio of TGF 1 and receptor AT1 was scored from 0 to
: 0, no expression; 1, focal expression; 2, diffuse expression.
Statistics
Statistics were performed using SPSS 15.0 for Windows. Data were
presented as mean values  standard deviation (SD); except as
otherwise stated. Quantitative variables first analyzed concerning
Gaussian distribution were then subjected to the analysis of
variance (ANOVA; parametric) or Kruskal-Wallis test (nonpara-
metric). Categorical variables were analyzed using Fisher exact test.
Differences were considered statistically significant when P  .05.
RESULTS
During cold preservation, UW showed the highest average
release rates of AST, ALT, and LDH. Compared with UW,
AST was significantly lower in SS, FBP, and SNAC 200
groups (P  .001); ALT was lower in group FBP (P  .023)
and LDH was lower in FBP and SNAC 200 groups (P 
007).
After reperfusion, serum levels of hepatic enzymes (AST,
LT, and LDH) and TBARS were not different among the
roups (Table 1). Taking UW as the standard, there were
ignificant differences regarding catalase and glutathione
evels using the other solutions. Levels of renin were higher
ith SNAC  UW.
No preservation injury was observed in any of the 5
roups. Mild and focal hepatic ballooning and focal sinu-
oidal congestion were noted in all UW, SNAC 200, and
NAC  UW samples. Focal sinusoidal congestion was
resent in 1 SS and no FBP sample; focal hepatic balloon-
ng was found in 4 SS (n  4) and in all FBP samples (n 
). There was steatosis in30% of hepatocytes in 2 samples
of the UW group (n  2), 1 of the SNAC  UW group
n 1), and 1 of the FBP group (n 1). Focal necrosis was
eported in 2 preserved samples in the SNAC and 1 in the
S group (n  1).
Expression of TGF 1 and AT1 receptor was not de-
tected in any sample.
DISCUSSION
I/R injury in liver transplantation is a complex phenomenon
that contributes to severe complications like primary non-
function, primary dysfunction, and nonanastomotic biliary
stricture.16 Preservation solutions seek to minimize injury
to the organ. UW is certainly the most used preservation
solution for liver transplantation but it is not ideal.17
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3636 CAMACHO, FRAGA, SOUZA ET ALIn the present study, SNAC 200 and FBP solutions were
more protective to the organ during 6 hours of cold
preservation compared with UW and SNAC  UW solu-
tions. FBP has been reported in some studies to exert
protective effects on I/R.18,19 Our previous studies of SNAC
and FBP showed good results.20,21 When we compared
NAC with FBP for the first time in the present study, we
oted SNAC to be as effective as FBP. The superiority of
NAC and FBP compared with UW during cold ischemia in
ntriguing.
UW solution is known to prevent hypothermic effects
uch as blunting of cellular edema and intracellular acido-
is.19 Moresco et al reported FBP to be superior to UW in
cold ischemia model. In this study and in that of Mota al22
were confirmed. Maybe the lower viscosity of FBP in
comparison with UW is the main cause for the better
results. Thus, it is believed that the lower viscosity in SNAC
and FBP may be one of the beneficial features to achieve a
more homogeneous organ perfusion and better protection
of cellular and endothelial barriers. The protective action of
SNAC during cold ischemia still remains obscure, but it
may relate to protective effects of nitric oxide after reper-
fusion.
We have observed a protective role of SS on cold
ischemia. A hypothermic process may help organ preserva-
tion but it does not explain the results after reperfusion. SS
may have some oxidant effect as shown by hypertonic SS
working as an immunomodulator of T-cell, neutrophil, and
macrophage function.23
As expected, no anatomopathological preservation le-
sions were observed, which may relate to the short reper-
fusion period. There was no expression of TGF 1 or AT1
receptor in the samples probably because of the short
reperfusion period. A longer reperfusion period would be
necessary because these cytokines are stimulated later in
the cascade of the fibrogenesis process.24 In contrast, lower
enin levels, which are present at outset of the cascade,
ere observed among livers preserved with FBP and SNAC
ompared with UW, suggesting that fibrogenesis may be
ore active with UW than with the other solutions. We
bserved that the combination of UW  SNAC produced
ore renin possibly secondary to unfavorable interactions
f some of the compounds.
In conclusion, we have suggested that I/R injury induces
brogenesis, as shown by renin activity levels. To prevent
brogenesis, FBP and SNAC media were superior to UW
olution.
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